Matches in SemOpenAlex for { <https://semopenalex.org/work/W1995308188> ?p ?o ?g. }
- W1995308188 endingPage "924" @default.
- W1995308188 startingPage "909" @default.
- W1995308188 abstract "Abstract Currently available progesterone (P4) receptor (PR) antagonists, such as mifepristone (RU486), lack specificity and display partial agonist properties, leading to potential drawbacks in their clinical use. Recent x-ray crystallographic studies have identified key contacts involved in the binding of agonists and antagonists with PR opening the way for a new rational strategy for inactivating PR. We report here the synthesis and characterization of a novel class of PR antagonists (APRn) designed from such studies. The lead molecule, the homosteroid APR19, displays in vivo endometrial anti-P4 activity. APR19 inhibits P4-induced PR recruitment and transactivation from synthetic and endogenous gene promoters. Importantly, it exhibits high PR selectivity with respect to other steroid hormone receptors and is devoid of any partial agonist activity on PR target gene transcription. Two-hybrid and immunostaining experiments reveal that APR19-bound PR is unable to interact with either steroid receptor coactivators 1 and 2 (SRC1 and SCR2) or nuclear receptor corepressor (NcoR) and silencing mediator of retinoid acid and thyroid hormone receptor (SMRT), in contrast to RU486-PR complexes. APR19 also inhibits agonist-induced phosphorylation of serine 294 regulating PR transcriptional activity and turnover kinetics. In silico docking studies based on the crystal structure of the PR ligand-binding domain show that, in contrast to P4, APR19 does not establish stabilizing hydrogen bonds with the ligand-binding cavity, resulting in an unstable ligand-receptor complex. Altogether, these properties highly distinguish APR19 from RU486 and likely its derivatives, suggesting that it belongs to a new class of pure antiprogestins that inactivate PR by a passive mechanism. These specific PR antagonists open new perspectives for long-term hormonal therapy." @default.
- W1995308188 created "2016-06-24" @default.
- W1995308188 creator A5004024358 @default.
- W1995308188 creator A5004646984 @default.
- W1995308188 creator A5020514123 @default.
- W1995308188 creator A5050225719 @default.
- W1995308188 creator A5055239625 @default.
- W1995308188 creator A5061943751 @default.
- W1995308188 creator A5063718814 @default.
- W1995308188 creator A5067053123 @default.
- W1995308188 creator A5073621488 @default.
- W1995308188 creator A5075282244 @default.
- W1995308188 creator A5075374556 @default.
- W1995308188 creator A5088436528 @default.
- W1995308188 creator A5091167716 @default.
- W1995308188 date "2013-06-01" @default.
- W1995308188 modified "2023-10-18" @default.
- W1995308188 title "A New Strategy for Selective Targeting of Progesterone Receptor With Passive Antagonists" @default.
- W1995308188 cites W1484666375 @default.
- W1995308188 cites W1586699954 @default.
- W1995308188 cites W1588517436 @default.
- W1995308188 cites W1593442063 @default.
- W1995308188 cites W1749258448 @default.
- W1995308188 cites W1907321242 @default.
- W1995308188 cites W1971746926 @default.
- W1995308188 cites W1971949613 @default.
- W1995308188 cites W1972848037 @default.
- W1995308188 cites W1974171707 @default.
- W1995308188 cites W1979136542 @default.
- W1995308188 cites W1984433201 @default.
- W1995308188 cites W1984751527 @default.
- W1995308188 cites W1986914259 @default.
- W1995308188 cites W1989150626 @default.
- W1995308188 cites W1992927495 @default.
- W1995308188 cites W1993482635 @default.
- W1995308188 cites W1996061414 @default.
- W1995308188 cites W2000011119 @default.
- W1995308188 cites W2000777228 @default.
- W1995308188 cites W2004857981 @default.
- W1995308188 cites W2007624933 @default.
- W1995308188 cites W2008539728 @default.
- W1995308188 cites W2014232493 @default.
- W1995308188 cites W2016921243 @default.
- W1995308188 cites W2017240941 @default.
- W1995308188 cites W2021087685 @default.
- W1995308188 cites W2023307129 @default.
- W1995308188 cites W2023398724 @default.
- W1995308188 cites W2026370277 @default.
- W1995308188 cites W2026731274 @default.
- W1995308188 cites W2037043326 @default.
- W1995308188 cites W2048957217 @default.
- W1995308188 cites W2059329687 @default.
- W1995308188 cites W2063169494 @default.
- W1995308188 cites W2065958815 @default.
- W1995308188 cites W2067291023 @default.
- W1995308188 cites W2070327310 @default.
- W1995308188 cites W2074624944 @default.
- W1995308188 cites W2076978030 @default.
- W1995308188 cites W2079780982 @default.
- W1995308188 cites W2082368668 @default.
- W1995308188 cites W2085448623 @default.
- W1995308188 cites W2087525462 @default.
- W1995308188 cites W2087588579 @default.
- W1995308188 cites W2103794058 @default.
- W1995308188 cites W2103883528 @default.
- W1995308188 cites W2104687197 @default.
- W1995308188 cites W2107875803 @default.
- W1995308188 cites W2112316723 @default.
- W1995308188 cites W2114500987 @default.
- W1995308188 cites W2115210458 @default.
- W1995308188 cites W2119638687 @default.
- W1995308188 cites W2119963782 @default.
- W1995308188 cites W2128840922 @default.
- W1995308188 cites W2131059659 @default.
- W1995308188 cites W2131290017 @default.
- W1995308188 cites W2133270411 @default.
- W1995308188 cites W2133341433 @default.
- W1995308188 cites W2134106368 @default.
- W1995308188 cites W2142180343 @default.
- W1995308188 cites W2147700987 @default.
- W1995308188 cites W2148131050 @default.
- W1995308188 cites W2151922331 @default.
- W1995308188 cites W2153131119 @default.
- W1995308188 cites W270887500 @default.
- W1995308188 cites W4252456312 @default.
- W1995308188 doi "https://doi.org/10.1210/me.2012-1328" @default.
- W1995308188 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5415273" @default.
- W1995308188 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23579486" @default.
- W1995308188 hasPublicationYear "2013" @default.
- W1995308188 type Work @default.
- W1995308188 sameAs 1995308188 @default.
- W1995308188 citedByCount "15" @default.
- W1995308188 countsByYear W19953081882014 @default.
- W1995308188 countsByYear W19953081882015 @default.
- W1995308188 countsByYear W19953081882016 @default.
- W1995308188 countsByYear W19953081882020 @default.
- W1995308188 countsByYear W19953081882021 @default.
- W1995308188 countsByYear W19953081882022 @default.